Why did the FDA report zero PDUFA VII hires for FY2026?

In its July 2026 update, the FDA disclosed that no hires were made under PDUFA VII or BsUFA III for FY2026, with every hiring category showing 0% completion. Persistent vacancies from FY24 and FY25 continue, suggesting structural recruitment challenges that could hinder the agency’s ability to meet review goals for drug and biosimilar applications.